Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
29.69
-0.01 (-0.03%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $8.39 billion as of October 12, 2026. It is the 2,478th most valuable company in the world and the 851st biggest in the United States. Its market cap has decreased by 2.12% in one year.
Market Cap
8.39B
Enterprise Value
8.05B
1-Year Change
-2.12%
Global Rank
Country Rank
#851 United States
Category
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $8.39B, an increase of 40.90%. That is a compound annual growth rate of 29.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 8.39B | 10.22% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 9.83B |
| Twist Bioscience | 9.52B |
| Protagonist Therapeutics | 9.37B |
| Kymera Therapeutics | 9.32B |
| Cytokinetics | 8.73B |
| Axsome Therapeutics | 8.70B |
| Arrowhead Pharmaceuticals | 8.58B |
| Spyre Therapeutics | 8.03B |